Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-18-017207

Executive VP, Global R&D gave up 1,555 shares (to pay taxes)

  • Executive VP, Global R&D acquired 4,597 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fridriksdottir Hafrun · Executive VP, Global R&D

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-04 Exercise or conversion : show line 1 in the form +1,165 4,509.51 D
2018-03-05 Exercise or conversion : show line 2 in the form +3,432 7,941.51 D
2018-03-05 Shares withheld for taxes : show line 3 in the form −400 $19.38 $7,752 7,541.51 D
2018-03-05 Shares withheld for taxes : show line 4 in the form −1,155 $19.38 $22,384 6,386.51 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-03-04 Exercise or conversion : show line 5 in the form Restricted Share Units −1,165 1,165 D
2018-03-05 Exercise or conversion : show line 6 in the form Restricted Share Units −3,432 0 D
Loading xslF345X03/doc4.xml…